CLLS compared with SGHT: revenue, margins and what each company keeps, and the suppliers and customers both name

CLLSCellectis S.A.

Mkt capRevenueRevenue

SGHTSight Sciences, Inc.

Mkt capRevenueRevenue

Compare

CLLSCellectis S.A.

SGHTSight Sciences, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only CLLS 4

TMOLife Technologiessupplier

ALLOAllogene Therapeuticscustomer

AZNAstraZeneca AB (AZ Ireland)customer

—Servierunlistedcustomer

Shared 0

No disclosed counterparties: SGHT.

Only SGHT 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

CLLSCellectis S.A.

1.06▼−1.85%· post 1.04

Mkt cap$108.4MRevenue—Revenue—

SGHTSight Sciences, Inc.

9.14▼−1.98%· post 9.14

ClosedNov 2 '26

Mkt cap$513.4MRevenue$23MQ2 FY26Revenue$77MFY25

Compare

ClosedNov 2 '26

CLLSCellectis S.A.

SGHTSight Sciences, Inc.

1.06▼−1.85%post 1.04

Price

9.14▼−1.98%post 9.14

$108.4M

Mkt cap

$513.4M

—

Revenue

$23MQ2 FY26

—

Revenue

$77MFY25

CLLS1.06▼−1.85%vsSGHT9.14▼−1.98%ClosedNov 2 '26